New hires and promotions in the med-tech industry, including: Inogen, Onlume, Pacific Biosciences of California, Renovacare, Rti Surgical Holdings, Scipher Medicine.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 4web Medical, Atomic Blue, Dexcom, Hangzhou Biotest Biotech, Incelldx, Seasun Biomaterials, Sekisui Diagnostics, Vasoptic Medical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bacainn, Curis, F2G, Fulcrum, Pharnext, Redhill, Rezolute, Vertex.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adagene, Adgero, Alligator, Alphamab, Aptevo, Autotelic, Biocryst, Bryn, Bryologyx, Curadigm, Debiopharm, Delmar, Denali, Dyadic, E-therapeutics, Intomics, Izana, J&J, L.E.A.F., Lyvgen, Mateon, Melinta, Menarini, Merck, Metuchen, Midatech, Mitsubishi Tanabe, Nanobiotix, Nantkwest, Neurotrope, Orgenesis, Ose, Panacea, Pharmabcine, Qualigen, Refana, Secura, Stemline, Supernus, Takeda, Tetraphase, US Worldmeds, Zealand.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Biondvax, Catalyst, Dermata, Devonian, Impel, Merck, Opthea, Orpheris, Pfizer, Pulmatrix, Tychan.

Biopharmas raising money in public or private financings, including: Aileron, Amyris, Antibe, Appili, Applied Molecular Transport, Can-Fite, Fulcrum, Immunic, Innocan, Legend, Oncology Venture, Vedanta.

New hires and promotions in the biopharma industry, including: Azafaros, Confo, Gritstone, Legend, Oric, Tonix, Verrica.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ability, Acepodia, Aicuris, Alphamab Oncology, Applied Biomath, Azitra, BMS, Brainstorm Cell, Canbridge, Cardiff, Chelation, Cn, Cortexyme, Debiopharm, Destiny, Fujifilm, IGY Immune, Isoplexis, Kalytera, Leading Biosciences, Meabco, Nanomab, Nanoviricides, Oncology Ventures, Ose, Pharmamar, Royalty Pharma, Sanofi, Sensorion, Serimmune, Theracour, Thermogenesis, TTY, Twist, Ubivac, Valneva, Verity.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Astellas, Astrazeneca, Bergenbio, Celltrion, CSL Behring, Eli Lilly, Fibrogen, Innovent, Inovio, Junshi, Kiniksa, Neurorx, Novartis, Relief, Sosei, Takeda.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Agenus, Algernon, Arch, Beigene, Cellenkos, Clarity, Elixirgen, FSD, Helsinn, Kiniksa, Lupin, Mylan, Oncolys, Revive, Specialised, Taiho, Trevena.